In simple terms, Talaris Therapeutics, Inc. has 42.811 M shares that people are buying and selling right now.
Return on Investments
The company's asset efficiency, represented by a robust -0.433% return, is a testament to Talaris Therapeutics, Inc.'s adeptness in optimizing resource deployment. Talaris Therapeutics, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.402%. Furthermore, the proficiency of Talaris Therapeutics, Inc. in capital utilization is underscored by a remarkable -0.538% return on capital employed.
Stock Prices
Talaris Therapeutics, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.96, while its low point bottomed out at $2.82. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Talaris Therapeutics, Inc.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
